Global Drugs for Herpes Labialis (Oral Herpes) Sales Market Report 2021

世界の口唇ヘルペス治療薬販売市場2021

◆タイトル:Global Drugs for Herpes Labialis (Oral Herpes) Sales Market Report 2021
◆商品コード:QYR21JN7655
◆調査・発行会社:QYResearch
◆発行日:2021年4月7日
◆ページ数:140
◆レポート形式:(印刷可能)PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥440,000見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD6,000 ⇒換算¥660,000見積依頼/購入/質問フォーム
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常2日~3日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearchの日本における正規販売代理店です。

【レポートの概要】

QYリサーチ社の本調査レポートでは、世界の口唇ヘルペス治療薬市場について種類別(アシクロビル、バラシクロビル、ファムシクロビル、ドコサノール、その他)、用途別(外用、経口、注射)、地域別(アメリカ、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2016年~2027年までの市場規模と予測(販売量、売上、価格)、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。
・口唇ヘルペス治療薬市場の概要
・世界の主要地域別口唇ヘルペス治療薬市場規模2016-2027
・主要プレイヤーの競争状況・市場シェア
・世界の口唇ヘルペス治療薬市場規模2016-2021:種類別(アシクロビル、バラシクロビル、ファムシクロビル、ドコサノール、その他)
・世界の口唇ヘルペス治療薬市場予測2012-2027:種類別(アシクロビル、バラシクロビル、ファムシクロビル、ドコサノール、その他)
・世界の口唇ヘルペス治療薬市場規模2016-2021:用途別(外用、経口、注射)
・世界の口唇ヘルペス治療薬市場予測2012-2027:用途別(外用、経口、注射)
・口唇ヘルペス治療薬のアメリカ市場規模と予測2016-2021
・口唇ヘルペス治療薬のヨーロッパ市場規模と予測2016-2021
・口唇ヘルペス治療薬の中国市場規模と予測2016-2021
・口唇ヘルペス治療薬の日本市場規模と予測2016-2021
・口唇ヘルペス治療薬の東南アジア市場規模と予測2016-2021
・口唇ヘルペス治療薬のインド市場規模と予測2016-2021
・主要プレイヤーの企業情報:事業概要・売上・企業動向
(GSK、Novartis、Teva、Mylan、Cadila、Apotex、Daewoong Pharmaceutical、Livzon、Luoxin、Med shine、Bayer (Campho Phenique)、Blistex、Kelun、Hikma、Haiwang、Carmex、Cipher)
・口唇ヘルペス治療薬の製造コスト分析
・販売チャネル、流通業者、顧客
・口唇ヘルペス治療薬の市場動向・機会・課題
・調査の結論

Herpes Labialis (Oral Herpes) is a type of herpes simplex occurring on the lip, i.e. an infection caused by herpes simplex virus (HSV). An outbreak typically causes small blisters or sores on or around the mouth. The sores typically heal within 2–3 weeks, but the herpes virus remains dormant in the facial nerves, following orofacial infection, periodically reactivating (in symptomatic people) to create sores in the same area of the mouth or face at the site of the original infection.
Herpes Simplex Virus (HSV) is a commonly found human pathogen. Globally, an estimated 4.0 billion people are infected with Herpes Virus. The incidence rate of cold sores, caused by the HSV1 virus, is the second largest worldwide, trailing only behind common cold. About 79% of the US population is infected with HSV1, with about 25-35% of the adults enduring recurrent spate of cold sores. In all, close to 100 million outbreaks of cold sores occur each year in the US.

The classification of drugs for herpes labialis (oral herpes) includes valacyclovir, aciclovir, famciclovir, docosanol and other. The proportion of aciclovir in 2016 is about 17%, and the proportion of valacyclovir is about 45%.

Drugs for herpes labialis (oral herpes) are widely used though external use, oral and injection. The most proportion of drugs for herpes labialis (oral herpes) is oral, and the consumption in 2016 is about 1200 M USD.

North America is the largest consumption place, with a revenue market share nearly 36.5% in 2016. Following North America, Europe is the second largest consumption place with the revenue market share of 28.4%.

Market competition is intense. GSK, Novartis, Teva, Mylan, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.

Market Analysis and Insights: Global Drugs for Herpes Labialis (Oral Herpes) Market
The global Drugs for Herpes Labialis (Oral Herpes) market was valued at US$ 2506.5 in 2020 and will reach US$ 3378.1 million by the end of 2027, growing at a CAGR of 5.1% during 2022-2027.

Global Drugs for Herpes Labialis (Oral Herpes) Scope and Market Size
The global Drugs for Herpes Labialis (Oral Herpes) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Drugs for Herpes Labialis (Oral Herpes) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
Aciclovir
Valacyclovir
Famciclovir
Docosanol
Other

Segment by Application
External Use
Oral
Injection

The Drugs for Herpes Labialis (Oral Herpes) market is analysed and market size information is provided by regions (countries). Segment by Application, the Drugs for Herpes Labialis (Oral Herpes) market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
GSK
Novartis
Teva
Mylan
Cadila
Apotex
Daewoong Pharmaceutical
Livzon
Luoxin
Med shine
Bayer (Campho Phenique)
Blistex
Kelun
Hikma
Haiwang
Carmex
Cipher

【レポートの目次】

1 Drugs for Herpes Labialis (Oral Herpes) Market Overview
1.1 Drugs for Herpes Labialis (Oral Herpes) Product Scope
1.2 Drugs for Herpes Labialis (Oral Herpes) Segment by Type
1.2.1 Global Drugs for Herpes Labialis (Oral Herpes) Sales by Type (2016 & 2021 & 2027)
1.2.2 Aciclovir
1.2.3 Valacyclovir
1.2.4 Famciclovir
1.2.5 Docosanol
1.2.6 Other
1.3 Drugs for Herpes Labialis (Oral Herpes) Segment by Application
1.3.1 Global Drugs for Herpes Labialis (Oral Herpes) Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 External Use
1.3.3 Oral
1.3.4 Injection
1.4 Drugs for Herpes Labialis (Oral Herpes) Market Estimates and Forecasts (2016-2027)
1.4.1 Global Drugs for Herpes Labialis (Oral Herpes) Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Drugs for Herpes Labialis (Oral Herpes) Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Drugs for Herpes Labialis (Oral Herpes) Price Trends (2016-2027)

2 Drugs for Herpes Labialis (Oral Herpes) Estimates and Forecasts by Region
2.1 Global Drugs for Herpes Labialis (Oral Herpes) Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Drugs for Herpes Labialis (Oral Herpes) Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Region (2016-2021)
2.2.2 Global Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Region (2016-2021)
2.3 Global Drugs for Herpes Labialis (Oral Herpes) Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Drugs for Herpes Labialis (Oral Herpes) Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Drugs for Herpes Labialis (Oral Herpes) Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Drugs for Herpes Labialis (Oral Herpes) Estimates and Projections (2016-2027)
2.4.2 Europe Drugs for Herpes Labialis (Oral Herpes) Estimates and Projections (2016-2027)
2.4.3 China Drugs for Herpes Labialis (Oral Herpes) Estimates and Projections (2016-2027)
2.4.4 Japan Drugs for Herpes Labialis (Oral Herpes) Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Drugs for Herpes Labialis (Oral Herpes) Estimates and Projections (2016-2027)
2.4.6 India Drugs for Herpes Labialis (Oral Herpes) Estimates and Projections (2016-2027)
3 Global Drugs for Herpes Labialis (Oral Herpes) Competition Landscape by Players
3.1 Global Top Drugs for Herpes Labialis (Oral Herpes) Players by Sales (2016-2021)
3.2 Global Top Drugs for Herpes Labialis (Oral Herpes) Players by Revenue (2016-2021)
3.3 Global Drugs for Herpes Labialis (Oral Herpes) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Drugs for Herpes Labialis (Oral Herpes) as of 2020)
3.4 Global Drugs for Herpes Labialis (Oral Herpes) Average Price by Company (2016-2021)
3.5 Manufacturers Drugs for Herpes Labialis (Oral Herpes) Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Drugs for Herpes Labialis (Oral Herpes) Market Size by Type
4.1 Global Drugs for Herpes Labialis (Oral Herpes) Historic Market Review by Type (2016-2021)
4.1.1 Global Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Type (2016-2021)
4.1.2 Global Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Type (2016-2021)
4.1.3 Global Drugs for Herpes Labialis (Oral Herpes) Price by Type (2016-2021)
4.2 Global Drugs for Herpes Labialis (Oral Herpes) Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Drugs for Herpes Labialis (Oral Herpes) Sales Forecast by Type (2022-2027)
4.2.2 Global Drugs for Herpes Labialis (Oral Herpes) Revenue Forecast by Type (2022-2027)
4.2.3 Global Drugs for Herpes Labialis (Oral Herpes) Price Forecast by Type (2022-2027)
5 Global Drugs for Herpes Labialis (Oral Herpes) Market Size by Application
5.1 Global Drugs for Herpes Labialis (Oral Herpes) Historic Market Review by Application (2016-2021)
5.1.1 Global Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Application (2016-2021)
5.1.2 Global Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Application (2016-2021)
5.1.3 Global Drugs for Herpes Labialis (Oral Herpes) Price by Application (2016-2021)
5.2 Global Drugs for Herpes Labialis (Oral Herpes) Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Drugs for Herpes Labialis (Oral Herpes) Sales Forecast by Application (2022-2027)
5.2.2 Global Drugs for Herpes Labialis (Oral Herpes) Revenue Forecast by Application (2022-2027)
5.2.3 Global Drugs for Herpes Labialis (Oral Herpes) Price Forecast by Application (2022-2027)

6 North America Drugs for Herpes Labialis (Oral Herpes) Market Facts & Figures
6.1 North America Drugs for Herpes Labialis (Oral Herpes) Sales by Company
6.1.1 North America Drugs for Herpes Labialis (Oral Herpes) Sales by Company (2016-2021)
6.1.2 North America Drugs for Herpes Labialis (Oral Herpes) Revenue by Company (2016-2021)
6.2 North America Drugs for Herpes Labialis (Oral Herpes) Sales Breakdown by Type
6.2.1 North America Drugs for Herpes Labialis (Oral Herpes) Sales Breakdown by Type (2016-2021)
6.2.2 North America Drugs for Herpes Labialis (Oral Herpes) Sales Breakdown by Type (2022-2027)
6.3 North America Drugs for Herpes Labialis (Oral Herpes) Sales Breakdown by Application
6.3.1 North America Drugs for Herpes Labialis (Oral Herpes) Sales Breakdown by Application (2016-2021)
6.3.2 North America Drugs for Herpes Labialis (Oral Herpes) Sales Breakdown by Application (2022-2027)

7 Europe Drugs for Herpes Labialis (Oral Herpes) Market Facts & Figures
7.1 Europe Drugs for Herpes Labialis (Oral Herpes) Sales by Company
7.1.1 Europe Drugs for Herpes Labialis (Oral Herpes) Sales by Company (2016-2021)
7.1.2 Europe Drugs for Herpes Labialis (Oral Herpes) Revenue by Company (2016-2021)
7.2 Europe Drugs for Herpes Labialis (Oral Herpes) Sales Breakdown by Type
7.2.1 Europe Drugs for Herpes Labialis (Oral Herpes) Sales Breakdown by Type (2016-2021)
7.2.2 Europe Drugs for Herpes Labialis (Oral Herpes) Sales Breakdown by Type (2022-2027)
7.3 Europe Drugs for Herpes Labialis (Oral Herpes) Sales Breakdown by Application
7.3.1 Europe 140 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 140 Sales Breakdown by Application (2022-2027)

8 China Drugs for Herpes Labialis (Oral Herpes) Market Facts & Figures
8.1 China Drugs for Herpes Labialis (Oral Herpes) Sales by Company
8.1.1 China Drugs for Herpes Labialis (Oral Herpes) Sales by Company (2016-2021)
8.1.2 China Drugs for Herpes Labialis (Oral Herpes) Revenue by Company (2016-2021)
8.2 China Drugs for Herpes Labialis (Oral Herpes) Sales Breakdown by Type
8.2.1 China Drugs for Herpes Labialis (Oral Herpes) Sales Breakdown by Type (2016-2021)
8.2.2 China Drugs for Herpes Labialis (Oral Herpes) Sales Breakdown by Type (2022-2027)
8.3 China Drugs for Herpes Labialis (Oral Herpes) Sales Breakdown by Application
8.3.1 China 310 Sales Breakdown by Application (2016-2021)
8.3.2 China 310 Sales Breakdown by Application (2022-2027)

9 Japan Drugs for Herpes Labialis (Oral Herpes) Market Facts & Figures
9.1 Japan Drugs for Herpes Labialis (Oral Herpes) Sales by Company
9.1.1 Japan Drugs for Herpes Labialis (Oral Herpes) Sales by Company (2016-2021)
9.1.2 Japan Drugs for Herpes Labialis (Oral Herpes) Revenue by Company (2016-2021)
9.2 Japan Drugs for Herpes Labialis (Oral Herpes) Sales Breakdown by Type
9.2.1 Japan Drugs for Herpes Labialis (Oral Herpes) Sales Breakdown by Type (2016-2021)
9.2.2 Japan Drugs for Herpes Labialis (Oral Herpes) Sales Breakdown by Type (2022-2027)
9.3 Japan Drugs for Herpes Labialis (Oral Herpes) Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Drugs for Herpes Labialis (Oral Herpes) Market Facts & Figures
10.1 Southeast Asia Drugs for Herpes Labialis (Oral Herpes) Sales by Company
10.1.1 Southeast Asia Drugs for Herpes Labialis (Oral Herpes) Sales by Company (2016-2021)
10.1.2 Southeast Asia Drugs for Herpes Labialis (Oral Herpes) Revenue by Company (2016-2021)
10.2 Southeast Asia Drugs for Herpes Labialis (Oral Herpes) Sales Breakdown by Type
10.2.1 Southeast Asia Drugs for Herpes Labialis (Oral Herpes) Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Drugs for Herpes Labialis (Oral Herpes) Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Drugs for Herpes Labialis (Oral Herpes) Sales Breakdown by Application
10.3.1 Southeast Asia K MT Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K MT Sales Breakdown by Application (2022-2027)

11 India Drugs for Herpes Labialis (Oral Herpes) Market Facts & Figures
11.1 India Drugs for Herpes Labialis (Oral Herpes) Sales by Company
11.1.1 India Drugs for Herpes Labialis (Oral Herpes) Sales by Company (2016-2021)
11.1.2 India Drugs for Herpes Labialis (Oral Herpes) Revenue by Company (2016-2021)
11.2 India Drugs for Herpes Labialis (Oral Herpes) Sales Breakdown by Type
11.2.1 India Drugs for Herpes Labialis (Oral Herpes) Sales Breakdown by Type (2016-2021)
11.2.2 India Drugs for Herpes Labialis (Oral Herpes) Sales Breakdown by Type (2022-2027)
11.3 India Drugs for Herpes Labialis (Oral Herpes) Sales Breakdown by Application
11.3.1 India Drugs for Herpes Labialis (Oral Herpes) Sales Breakdown by Application (2016-2021)
11.3.2 India Drugs for Herpes Labialis (Oral Herpes) Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Drugs for Herpes Labialis (Oral Herpes) Business
12.1 GSK
12.1.1 GSK Corporation Information
12.1.2 GSK Business Overview
12.1.3 GSK Drugs for Herpes Labialis (Oral Herpes) Sales, Revenue and Gross Margin (2016-2021)
12.1.4 GSK Drugs for Herpes Labialis (Oral Herpes) Products Offered
12.1.5 GSK Recent Development
12.2 Novartis
12.2.1 Novartis Corporation Information
12.2.2 Novartis Business Overview
12.2.3 Novartis Drugs for Herpes Labialis (Oral Herpes) Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Novartis Drugs for Herpes Labialis (Oral Herpes) Products Offered
12.2.5 Novartis Recent Development
12.3 Teva
12.3.1 Teva Corporation Information
12.3.2 Teva Business Overview
12.3.3 Teva Drugs for Herpes Labialis (Oral Herpes) Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Teva Drugs for Herpes Labialis (Oral Herpes) Products Offered
12.3.5 Teva Recent Development
12.4 Mylan
12.4.1 Mylan Corporation Information
12.4.2 Mylan Business Overview
12.4.3 Mylan Drugs for Herpes Labialis (Oral Herpes) Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Mylan Drugs for Herpes Labialis (Oral Herpes) Products Offered
12.4.5 Mylan Recent Development
12.5 Cadila
12.5.1 Cadila Corporation Information
12.5.2 Cadila Business Overview
12.5.3 Cadila Drugs for Herpes Labialis (Oral Herpes) Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Cadila Drugs for Herpes Labialis (Oral Herpes) Products Offered
12.5.5 Cadila Recent Development
12.6 Apotex
12.6.1 Apotex Corporation Information
12.6.2 Apotex Business Overview
12.6.3 Apotex Drugs for Herpes Labialis (Oral Herpes) Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Apotex Drugs for Herpes Labialis (Oral Herpes) Products Offered
12.6.5 Apotex Recent Development
12.7 Daewoong Pharmaceutical
12.7.1 Daewoong Pharmaceutical Corporation Information
12.7.2 Daewoong Pharmaceutical Business Overview
12.7.3 Daewoong Pharmaceutical Drugs for Herpes Labialis (Oral Herpes) Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Daewoong Pharmaceutical Drugs for Herpes Labialis (Oral Herpes) Products Offered
12.7.5 Daewoong Pharmaceutical Recent Development
12.8 Livzon
12.8.1 Livzon Corporation Information
12.8.2 Livzon Business Overview
12.8.3 Livzon Drugs for Herpes Labialis (Oral Herpes) Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Livzon Drugs for Herpes Labialis (Oral Herpes) Products Offered
12.8.5 Livzon Recent Development
12.9 Luoxin
12.9.1 Luoxin Corporation Information
12.9.2 Luoxin Business Overview
12.9.3 Luoxin Drugs for Herpes Labialis (Oral Herpes) Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Luoxin Drugs for Herpes Labialis (Oral Herpes) Products Offered
12.9.5 Luoxin Recent Development
12.10 Med shine
12.10.1 Med shine Corporation Information
12.10.2 Med shine Business Overview
12.10.3 Med shine Drugs for Herpes Labialis (Oral Herpes) Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Med shine Drugs for Herpes Labialis (Oral Herpes) Products Offered
12.10.5 Med shine Recent Development
12.11 Bayer (Campho Phenique)
12.11.1 Bayer (Campho Phenique) Corporation Information
12.11.2 Bayer (Campho Phenique) Business Overview
12.11.3 Bayer (Campho Phenique) Drugs for Herpes Labialis (Oral Herpes) Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Bayer (Campho Phenique) Drugs for Herpes Labialis (Oral Herpes) Products Offered
12.11.5 Bayer (Campho Phenique) Recent Development
12.12 Blistex
12.12.1 Blistex Corporation Information
12.12.2 Blistex Business Overview
12.12.3 Blistex Drugs for Herpes Labialis (Oral Herpes) Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Blistex Drugs for Herpes Labialis (Oral Herpes) Products Offered
12.12.5 Blistex Recent Development
12.13 Kelun
12.13.1 Kelun Corporation Information
12.13.2 Kelun Business Overview
12.13.3 Kelun Drugs for Herpes Labialis (Oral Herpes) Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Kelun Drugs for Herpes Labialis (Oral Herpes) Products Offered
12.13.5 Kelun Recent Development
12.14 Hikma
12.14.1 Hikma Corporation Information
12.14.2 Hikma Business Overview
12.14.3 Hikma Drugs for Herpes Labialis (Oral Herpes) Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Hikma Drugs for Herpes Labialis (Oral Herpes) Products Offered
12.14.5 Hikma Recent Development
12.15 Haiwang
12.15.1 Haiwang Corporation Information
12.15.2 Haiwang Business Overview
12.15.3 Haiwang Drugs for Herpes Labialis (Oral Herpes) Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Haiwang Drugs for Herpes Labialis (Oral Herpes) Products Offered
12.15.5 Haiwang Recent Development
12.16 Carmex
12.16.1 Carmex Corporation Information
12.16.2 Carmex Business Overview
12.16.3 Carmex Drugs for Herpes Labialis (Oral Herpes) Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Carmex Drugs for Herpes Labialis (Oral Herpes) Products Offered
12.16.5 Carmex Recent Development
12.17 Cipher
12.17.1 Cipher Corporation Information
12.17.2 Cipher Business Overview
12.17.3 Cipher Drugs for Herpes Labialis (Oral Herpes) Sales, Revenue and Gross Margin (2016-2021)
12.17.4 Cipher Drugs for Herpes Labialis (Oral Herpes) Products Offered
12.17.5 Cipher Recent Development

13 Drugs for Herpes Labialis (Oral Herpes) Manufacturing Cost Analysis
13.1 Drugs for Herpes Labialis (Oral Herpes) Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Drugs for Herpes Labialis (Oral Herpes)
13.4 Drugs for Herpes Labialis (Oral Herpes) Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Drugs for Herpes Labialis (Oral Herpes) Distributors List
14.3 Drugs for Herpes Labialis (Oral Herpes) Customers

15 Market Dynamics
15.1 Drugs for Herpes Labialis (Oral Herpes) Market Trends
15.2 Drugs for Herpes Labialis (Oral Herpes) Drivers
15.3 Drugs for Herpes Labialis (Oral Herpes) Market Challenges
15.4 Drugs for Herpes Labialis (Oral Herpes) Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables
Table 1. Global Drugs for Herpes Labialis (Oral Herpes) Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Drugs for Herpes Labialis (Oral Herpes) Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Drugs for Herpes Labialis (Oral Herpes) Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Drugs for Herpes Labialis (Oral Herpes) Sales (K MT) by Region (2016-2021)
Table 5. Global Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Region (2016-2021)
Table 6. Global Drugs for Herpes Labialis (Oral Herpes) Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Drugs for Herpes Labialis (Oral Herpes) Revenue Share by Region (2016-2021)
Table 8. Global Drugs for Herpes Labialis (Oral Herpes) Sales (K MT) Forecast by Region (2022-2027)
Table 9. Global Drugs for Herpes Labialis (Oral Herpes) Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Drugs for Herpes Labialis (Oral Herpes) Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Drugs for Herpes Labialis (Oral Herpes) Revenue Share Forecast by Region (2022-2027)
Table 12. Global Drugs for Herpes Labialis (Oral Herpes) Sales (K MT) of Key Companies (2016-2021)
Table 13. Global Drugs for Herpes Labialis (Oral Herpes) Sales Share by Company (2016-2021)
Table 14. Global Drugs for Herpes Labialis (Oral Herpes) Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Drugs for Herpes Labialis (Oral Herpes) Revenue Share by Company (2016-2021)
Table 16. Global Drugs for Herpes Labialis (Oral Herpes) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drugs for Herpes Labialis (Oral Herpes) as of 2020)
Table 17. Global Drugs for Herpes Labialis (Oral Herpes) Average Price (USD/MT) of Key Company (2016-2021)
Table 18. Manufacturers Drugs for Herpes Labialis (Oral Herpes) Manufacturing Sites and Area Served
Table 19. Manufacturers Drugs for Herpes Labialis (Oral Herpes) Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Drugs for Herpes Labialis (Oral Herpes) Sales (K MT) by Type (2016-2021)
Table 22. Global Drugs for Herpes Labialis (Oral Herpes) Sales Share by Type (2016-2021)
Table 23. Global Drugs for Herpes Labialis (Oral Herpes) Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Drugs for Herpes Labialis (Oral Herpes) Price (USD/MT) by Type (2016-2021)
Table 25. Global Drugs for Herpes Labialis (Oral Herpes) Sales Share by Type (2022-2027)
Table 26. Global Drugs for Herpes Labialis (Oral Herpes) Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Drugs for Herpes Labialis (Oral Herpes) Revenue Share by Type (2022-2027)
Table 28. Global Drugs for Herpes Labialis (Oral Herpes) Price (USD/MT) by Type (2022-2027)
Table 29. Global Drugs for Herpes Labialis (Oral Herpes) Sales (K MT) by Application (2016-2021)
Table 30. Global Drugs for Herpes Labialis (Oral Herpes) Sales Share by Application (2016-2021)
Table 31. Global Drugs for Herpes Labialis (Oral Herpes) Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Drugs for Herpes Labialis (Oral Herpes) Price (USD/MT) by Application (2016-2021)
Table 33. Global Drugs for Herpes Labialis (Oral Herpes) Sales (K MT) by Application (2022-2027)
Table 34. Global Drugs for Herpes Labialis (Oral Herpes) Sales Share by Application (2022-2027)
Table 35. Global Drugs for Herpes Labialis (Oral Herpes) Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Drugs for Herpes Labialis (Oral Herpes) Revenue Share by Application (2022-2027)
Table 37. Global Drugs for Herpes Labialis (Oral Herpes) Price (USD/MT) by Application (2022-2027)
Table 38. North America Drugs for Herpes Labialis (Oral Herpes) Sales (K MT) by Company (2016-2021)
Table 39. North America Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Company (2016-2021)
Table 40. North America Drugs for Herpes Labialis (Oral Herpes) Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Company (2016-2021)
Table 42. North America Drugs for Herpes Labialis (Oral Herpes) Sales by Type (2016-2021) & (K MT)
Table 43. North America Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Type (2016-2021)
Table 44. North America Drugs for Herpes Labialis (Oral Herpes) Sales by Type (2022-2027) & (K MT)
Table 45. North America Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Type (2022-2027)
Table 46. North America Drugs for Herpes Labialis (Oral Herpes) Sales by Application (2016-2021) & (K MT)
Table 47. North America Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Application (2016-2021)
Table 48. North America Drugs for Herpes Labialis (Oral Herpes) Sales by Application (2022-2027) & (K MT)
Table 49. North America Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Application (2022-2027)
Table 50. Europe Drugs for Herpes Labialis (Oral Herpes) Sales (K MT) by Company (2016-2021)
Table 51. Europe Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Company (2016-2021)
Table 52. Europe Drugs for Herpes Labialis (Oral Herpes) Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Company (2016-2021)
Table 54. Europe Drugs for Herpes Labialis (Oral Herpes) Sales by Type (2016-2021) & (K MT)
Table 55. Europe Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Type (2016-2021)
Table 56. Europe Drugs for Herpes Labialis (Oral Herpes) Sales by Type (2022-2027) & (K MT)
Table 57. Europe Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Type (2022-2027)
Table 58. Europe Drugs for Herpes Labialis (Oral Herpes) Sales by Application (2016-2021) & (K MT)
Table 59. Europe Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Application (2016-2021)
Table 60. Europe Drugs for Herpes Labialis (Oral Herpes) Sales by Application (2022-2027) & (K MT)
Table 61. Europe Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Application (2022-2027)
Table 62. China Drugs for Herpes Labialis (Oral Herpes) Sales (K MT) by Company (2016-2021)
Table 63. China Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Company (2016-2021)
Table 64. China Drugs for Herpes Labialis (Oral Herpes) Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Company (2016-2021)
Table 66. China Drugs for Herpes Labialis (Oral Herpes) Sales by Type (2016-2021) & (K MT)
Table 67. China Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Type (2016-2021)
Table 68. China Drugs for Herpes Labialis (Oral Herpes) Sales by Type (2022-2027) & (K MT)
Table 69. China Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Type (2022-2027)
Table 70. China Drugs for Herpes Labialis (Oral Herpes) Sales by Application (2016-2021) & (K MT)
Table 71. China Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Application (2016-2021)
Table 72. China Drugs for Herpes Labialis (Oral Herpes) Sales by Application (2022-2027) & (K MT)
Table 73. China Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Application (2022-2027)
Table 74. Japan Drugs for Herpes Labialis (Oral Herpes) Sales (K MT) by Company (2016-2021)
Table 75. Japan Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Company (2016-2021)
Table 76. Japan Drugs for Herpes Labialis (Oral Herpes) Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Company (2016-2021)
Table 78. Japan Drugs for Herpes Labialis (Oral Herpes) Sales by Type (2016-2021) & (K MT)
Table 79. Japan Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Type (2016-2021)
Table 80. Japan Drugs for Herpes Labialis (Oral Herpes) Sales by Type (2022-2027) & (K MT)
Table 81. Japan Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Type (2022-2027)
Table 82. Japan Drugs for Herpes Labialis (Oral Herpes) Sales by Application (2016-2021) & (K MT)
Table 83. Japan Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Application (2016-2021)
Table 84. Japan Drugs for Herpes Labialis (Oral Herpes) Sales by Application (2022-2027) & (K MT)
Table 85. Japan Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Drugs for Herpes Labialis (Oral Herpes) Sales (K MT) by Company (2016-2021)
Table 87. Southeast Asia Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Drugs for Herpes Labialis (Oral Herpes) Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Drugs for Herpes Labialis (Oral Herpes) Sales by Type (2016-2021) & (K MT)
Table 91. Southeast Asia Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Drugs for Herpes Labialis (Oral Herpes) Sales by Type (2022-2027) & (K MT)
Table 93. Southeast Asia Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Drugs for Herpes Labialis (Oral Herpes) Sales by Application (2016-2021) & (K MT)
Table 95. Southeast Asia Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Drugs for Herpes Labialis (Oral Herpes) Sales by Application (2022-2027) & (K MT)
Table 97. Southeast Asia Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Application (2022-2027)
Table 98. India Drugs for Herpes Labialis (Oral Herpes) Sales (K MT) by Company (2016-2021)
Table 99. India Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Company (2016-2021)
Table 100. India Drugs for Herpes Labialis (Oral Herpes) Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Company (2016-2021)
Table 102. India Drugs for Herpes Labialis (Oral Herpes) Sales by Type (2016-2021) & (K MT)
Table 103. India Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Type (2016-2021)
Table 104. India Drugs for Herpes Labialis (Oral Herpes) Sales by Type (2022-2027) & (K MT)
Table 105. India Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Type (2022-2027)
Table 106. India Drugs for Herpes Labialis (Oral Herpes) Sales by Application (2016-2021) & (K MT)
Table 107. India Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Application (2016-2021)
Table 108. India Drugs for Herpes Labialis (Oral Herpes) Sales by Application (2022-2027) & (K MT)
Table 109. India Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Application (2022-2027)
Table 110. GSK Corporation Information
Table 111. GSK Description and Business Overview
Table 112. GSK Drugs for Herpes Labialis (Oral Herpes) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 113. GSK Drugs for Herpes Labialis (Oral Herpes) Product
Table 114. GSK Recent Development
Table 115. Novartis Corporation Information
Table 116. Novartis Description and Business Overview
Table 117. Novartis Drugs for Herpes Labialis (Oral Herpes) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 118. Novartis Drugs for Herpes Labialis (Oral Herpes) Product
Table 119. Novartis Recent Development
Table 120. Teva Corporation Information
Table 121. Teva Description and Business Overview
Table 122. Teva Drugs for Herpes Labialis (Oral Herpes) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 123. Teva Drugs for Herpes Labialis (Oral Herpes) Product
Table 124. Teva Recent Development
Table 125. Mylan Corporation Information
Table 126. Mylan Description and Business Overview
Table 127. Mylan Drugs for Herpes Labialis (Oral Herpes) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 128. Mylan Drugs for Herpes Labialis (Oral Herpes) Product
Table 129. Mylan Recent Development
Table 130. Cadila Corporation Information
Table 131. Cadila Description and Business Overview
Table 132. Cadila Drugs for Herpes Labialis (Oral Herpes) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 133. Cadila Drugs for Herpes Labialis (Oral Herpes) Product
Table 134. Cadila Recent Development
Table 135. Apotex Corporation Information
Table 136. Apotex Description and Business Overview
Table 137. Apotex Drugs for Herpes Labialis (Oral Herpes) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 138. Apotex Drugs for Herpes Labialis (Oral Herpes) Product
Table 139. Apotex Recent Development
Table 140. Daewoong Pharmaceutical Corporation Information
Table 141. Daewoong Pharmaceutical Description and Business Overview
Table 142. Daewoong Pharmaceutical Drugs for Herpes Labialis (Oral Herpes) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 143. Daewoong Pharmaceutical Drugs for Herpes Labialis (Oral Herpes) Product
Table 144. Daewoong Pharmaceutical Recent Development
Table 145. Livzon Corporation Information
Table 146. Livzon Drugs for Herpes Labialis (Oral Herpes) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 147. Livzon Description and Business Overview
Table 148. Livzon Drugs for Herpes Labialis (Oral Herpes) Product
Table 149. Livzon Recent Development
Table 150. Luoxin Corporation Information
Table 151. Luoxin Drugs for Herpes Labialis (Oral Herpes) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 152. Luoxin Description and Business Overview
Table 153. Luoxin Drugs for Herpes Labialis (Oral Herpes) Product
Table 154. Luoxin Recent Development
Table 155. Med shine Corporation Information
Table 156. Med shine Description and Business Overview
Table 157. Med shine Drugs for Herpes Labialis (Oral Herpes) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 158. Med shine Drugs for Herpes Labialis (Oral Herpes) Product
Table 159. Med shine Recent Development
Table 160. Bayer (Campho Phenique) Corporation Information
Table 161. Bayer (Campho Phenique) Description and Business Overview
Table 162. Bayer (Campho Phenique) Drugs for Herpes Labialis (Oral Herpes) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 163. Bayer (Campho Phenique) Drugs for Herpes Labialis (Oral Herpes) Product
Table 164. Bayer (Campho Phenique) Recent Development
Table 165. Blistex Corporation Information
Table 166. Blistex Description and Business Overview
Table 167. Blistex Drugs for Herpes Labialis (Oral Herpes) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 168. Blistex Drugs for Herpes Labialis (Oral Herpes) Product
Table 169. Blistex Recent Development
Table 170. Kelun Corporation Information
Table 171. Kelun Description and Business Overview
Table 172. Kelun Drugs for Herpes Labialis (Oral Herpes) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 173. Kelun Drugs for Herpes Labialis (Oral Herpes) Product
Table 174. Kelun Recent Development
Table 175. Hikma Corporation Information
Table 176. Hikma Description and Business Overview
Table 177. Hikma Drugs for Herpes Labialis (Oral Herpes) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 178. Hikma Drugs for Herpes Labialis (Oral Herpes) Product
Table 179. Hikma Recent Development
Table 180. Haiwang Corporation Information
Table 181. Haiwang Description and Business Overview
Table 182. Haiwang Drugs for Herpes Labialis (Oral Herpes) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 183. Haiwang Drugs for Herpes Labialis (Oral Herpes) Product
Table 184. Haiwang Recent Development
Table 185. Carmex Corporation Information
Table 186. Carmex Description and Business Overview
Table 187. Carmex Drugs for Herpes Labialis (Oral Herpes) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 188. Carmex Drugs for Herpes Labialis (Oral Herpes) Product
Table 189. Carmex Recent Development
Table 190. Cipher Corporation Information
Table 191. Cipher Description and Business Overview
Table 192. Cipher Drugs for Herpes Labialis (Oral Herpes) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 193. Cipher Drugs for Herpes Labialis (Oral Herpes) Product
Table 194. Cipher Recent Development
Table 195. Production Base and Market Concentration Rate of Raw Material
Table 196. Key Suppliers of Raw Materials
Table 197. Drugs for Herpes Labialis (Oral Herpes) Distributors List
Table 198. Drugs for Herpes Labialis (Oral Herpes) Customers List
Table 199. Drugs for Herpes Labialis (Oral Herpes) Market Trends
Table 200. Drugs for Herpes Labialis (Oral Herpes) Market Drivers
Table 201. Drugs for Herpes Labialis (Oral Herpes) Market Challenges
Table 202. Drugs for Herpes Labialis (Oral Herpes) Market Restraints
Table 203. Research Programs/Design for This Report
Table 204. Key Data Information from Secondary Sources
Table 205. Key Data Information from Primary Sources
List of Figures
Figure 1. Drugs for Herpes Labialis (Oral Herpes) Product Picture
Figure 2. Global Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Application in 2021 & 2027
Figure 6. External Use Examples
Figure 7. Oral Examples
Figure 8. Injection Examples
Figure 9. Global Drugs for Herpes Labialis (Oral Herpes) Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Drugs for Herpes Labialis (Oral Herpes) Sales Growth Rate (2016-2027) & (US$ Million)
Figure 11. Global Drugs for Herpes Labialis (Oral Herpes) Sales (K MT) Growth Rate (2016-2027)
Figure 12. Global Drugs for Herpes Labialis (Oral Herpes) Price Trends Growth Rate (2016-2027) (USD/MT)
Figure 13. Global Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Region: 2016 VS 2021
Figure 14. Global Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Region: 2021 VS 2027
Figure 15. North America Drugs for Herpes Labialis (Oral Herpes) Revenue (Million USD) Growth Rate (2016-2027)
Figure 16. North America Drugs for Herpes Labialis (Oral Herpes) Sales (K MT) Growth Rate (2016-2027)
Figure 17. Europe Drugs for Herpes Labialis (Oral Herpes) Revenue (Million USD) Growth Rate (2016-2027)
Figure 18. Europe Drugs for Herpes Labialis (Oral Herpes) Sales (Million USD) Growth Rate (2016-2027)
Figure 19. China Drugs for Herpes Labialis (Oral Herpes) Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. China Drugs for Herpes Labialis (Oral Herpes) Sales (Million USD) and Growth Rate (2016-2027)
Figure 21. Japan Drugs for Herpes Labialis (Oral Herpes) Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. Japan Drugs for Herpes Labialis (Oral Herpes) Sales (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Drugs for Herpes Labialis (Oral Herpes) Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Drugs for Herpes Labialis (Oral Herpes) Sales (Million USD) Growth Rate (2016-2027)
Figure 25. India Drugs for Herpes Labialis (Oral Herpes) Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. India Drugs for Herpes Labialis (Oral Herpes) Sales (Million USD) Growth Rate (2016-2027)
Figure 27. Global 5 Largest Drugs for Herpes Labialis (Oral Herpes) Players Market Share by Revenue in Drugs for Herpes Labialis (Oral Herpes): 2016 & 2020
Figure 28. Drugs for Herpes Labialis (Oral Herpes) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 29. Global Drugs for Herpes Labialis (Oral Herpes) Revenue Share by Type (2016-2021)
Figure 30. Global Drugs for Herpes Labialis (Oral Herpes) Revenue Growth Rate by Type in 2016 & 2020
Figure 31. Global Drugs for Herpes Labialis (Oral Herpes) Revenue Share by Application (2016-2021)
Figure 32. Global Drugs for Herpes Labialis (Oral Herpes) Revenue Growth Rate by Application in 2016 & 2020
Figure 33. North America Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Type in 2020
Figure 34. North America Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Application in 2020
Figure 35. Europe Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Type in 2020
Figure 36. Europe Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Application in 2020
Figure 37. China Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Type in 2020
Figure 38. China Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Application in 2020
Figure 39. Japan Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Type in 2020
Figure 40. Japan Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Application in 2020
Figure 41. Southeast Asia Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Type in 2020
Figure 42. Southeast Asia Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Application in 2020
Figure 43. India Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Type in 2020
Figure 44. India Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Application in 2020
Figure 45. Key Raw Materials Price Trend
Figure 46. Manufacturing Cost Structure of Drugs for Herpes Labialis (Oral Herpes)
Figure 47. Manufacturing Process Analysis of Drugs for Herpes Labialis (Oral Herpes)
Figure 48. Drugs for Herpes Labialis (Oral Herpes) Industrial Chain Analysis
Figure 49. Channels of Distribution
Figure 50. Distributors Profiles
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed


【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[世界の口唇ヘルペス治療薬販売市場2021] (Global Drugs for Herpes Labialis (Oral Herpes) Sales Market Report 2021 / QYR21JN7655)についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆